San Francisco startup iSono Health, developer of ATUSA™, the world’s first fully automated, portable, and wearable 3D breast ultrasound system, has raised funding from JSK Investments Group, as Vestbee was told.
- Launched in 2020 by Neda Razavi, iSono Health develops ATUSA™, a fully automated, portable, and wearable 3D breast ultrasound system.
- The device combines a wearable scanner with AI-powered software that captures and analyzes images in real time, allowing each breast to be screened in about two minutes without the need for a trained sonographer.
- Its cloud-based platform enables remote access, 3D visualization, and personalized monitoring, making preventive breast screening faster, easier, and more accessible.
- According to the firm, in early 2025 it secured approximately $5 million in funding, received the Frost & Sullivan 2023 US New Product Innovation Award, and launched an NIH-funded clinical study to validate its AI technology.
Details of the deal
- The round was led by JSK Investments Group, a Czech firm founded by Simona Kijonková that invests in companies to help them grow internationally.
“Healthcare is an industry with tremendous potential, and the founders’ story is always key. I come from a country with excellent healthcare and preventive services, but I know this is not the global standard. This is why I decided to invest in iSono Health to support technology that can make preventive breast screening accessible worldwide and help save lives," explains Simona Kijonková, Founder and Managing Partner at JSK Investments.
- iSono Health will use the funds to expand the reach of its ATUSA™ system, enhance its AI-driven image analysis, support ongoing NIH-backed clinical studies, and establish new partnerships with healthcare providers in underserved regions.
“We are thrilled to have JSK Investments as a strong international partner. We share a mission to make breast screening accessible, fast, and powered by advanced technology for women everywhere. This collaboration demonstrates how women-led companies can make a real global impact," claims Neda Razavi, CEO of iSono Health.
